Does LORLATINIB Cause Respiratory failure? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Respiratory failure have been filed in association with LORLATINIB (Lorbrena). This represents 0.6% of all adverse event reports for LORLATINIB.
33
Reports of Respiratory failure with LORLATINIB
0.6%
of all LORLATINIB reports
21
Deaths
14
Hospitalizations
How Dangerous Is Respiratory failure From LORLATINIB?
Of the 33 reports, 21 (63.6%) resulted in death, 14 (42.4%) required hospitalization, and 6 (18.2%) were considered life-threatening.
Is Respiratory failure Listed in the Official Label?
Yes, Respiratory failure is listed as a known adverse reaction in the official FDA drug label for LORLATINIB.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Off label use (394)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Dyspnoea (223)
Oedema peripheral (198)
Oedema (195)
Fatigue (188)
What Other Drugs Cause Respiratory failure?
PREDNISONE (2,299)
CYCLOPHOSPHAMIDE (2,096)
RITUXIMAB (1,838)
TACROLIMUS (1,758)
METHOTREXATE (1,685)
DEXAMETHASONE (1,603)
MYCOPHENOLATE MOFETIL (1,469)
METHYLPREDNISOLONE (1,442)
PREDNISOLONE (1,346)
VINCRISTINE (1,120)
Which LORLATINIB Alternatives Have Lower Respiratory failure Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE